Results 221 to 230 of about 901,832 (266)
Some of the next articles are maybe not open access.

Tumor marker determinations.

Acta medica Iugoslavica, 1991
A combination of 2 or 3 tumor markers was determined in the serum of 478 patients with malignant tumors. In 195 out of 213 patients with differentiated thyroid cancer and without relapse or metastases, the Tg concentration has undetectable. In 9 patients with nonfunctioning thyroid metastases the Tg level was correlated with the progress of the disease
Kusić, Zvonko   +5 more
openaire   +2 more sources

Circulating tumor markers in gynecological tumors

Current Opinion in Oncology, 1996
The correct use of tumor markers in patients with gynecological cancers can make an impact on management of the disease. Their value in screening for ovarian cancer cannot be recommended outside trials. Increased levels of various markers give prognostic information that could alter therapy for patients with early ovarian or cervical carcinoma.
openaire   +2 more sources

Tumoral markers in tumors of the pineal region

Neurochirurgie, 2015
In cases of pineal tumors, a germ cell tumor should always be suspected. As some of them are secreting tumors, tumoral markers (AFP and/or hGC) are an important part of the diagnostic process. Their positivity either in the serum and/or in the cerebrospinal fluid may lead to an accurate diagnosis, avoiding a potentially dangerous surgical biopsy ...
openaire   +2 more sources

[Markers of brain tumors].

Minerva medica, 1984
Biological markers of tumors are compounds or enzymatic activities measurable in body fluids. Their presence or concentration must be linked to tumoral growth. The markers of the central nervous system tumors are detected in CSF. Alpha-feto-protein, carcinoembryonic antigen, human chorionic gonadotropin, adenohypophyseal peptide hormones, enzymes, etc.,
R. Fumagalli   +3 more
openaire   +2 more sources

Tumor markers

Current Problems in Surgery, 1982
H P, Ewing, B D, Newsom, J D, Hardy
openaire   +2 more sources

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L. Siegel   +2 more
exaly  

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Heather Parsons   +2 more
exaly  

Tumor Markers

2014
Amitava Dasgupta, Amer Wahed
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

Tumor markers

Medical Oncology and Tumor Pharmacotherapy, 1991
openaire   +2 more sources

Home - About - Disclaimer - Privacy